Home JournalsJournal Details
ISSN: 1366-5278 eISSN: 2046-4924 CAS Zone: Medicine (Zone 3) Emerging Zone: Medicine (Zone 2) No

HEALTH TECHNOLOGY ASSESSMENT

Abbr. HEALTH TECHNOL ASSES ·ENGLAND ·Frequency Irregular ·Avg. articles/yr 95 articles
3.4
Latest IF
1.90%
Self-citation
较难
Submission difficulty
>12周,或约稿
Review cycle
About Journal

Health Technology Assessment (ISSN 1366-5278) is a prestigious academic journal published by the UK’s National Institute for Health and Care Research (NIHR) that serves as a leading venue for rigorous research in health technology assessment, medical policy, and health economics. The journal focuses on high-quality systematic reviews, cost-effectiveness analyses, and clinical effectiveness studies that inform evidence-based decision-making regarding medical interventions and technological applications. As an SCI-indexed publication, it holds a strong reputation for academic rigor and authority within its specialized field, attracting a highly professional readership of policymakers, clinicians, and health economists. While the journal is not currently open access, which may limit immediate full-text availability for some readers, its commitment to methodological excellence and substantial impact in the field of health technology assessment continues to establish it as a key resource for advancing evidence-based healthcare practices.

Recent Articles
2024-02-12
Journal Info
ISSN
1366-5278
Abbr.
HEALTH TECHNOL ASSES
Region
ENGLAND
Frequency
Irregular
CAS Zone
Medicine (Zone 3) · Non-Top
Emerging Zone
Medicine (Zone 2) · Non-Top
Open Access
No
Research Area
Medicine - Health Care
Coverage
Science Citation Index Expanded
Sub-categories
HEALTH CARE SCIENCES & SERVICESZone 3
Emerging Categories
HEALTH CARE SCIENCES & SERVICESZone 3
Submission & Homepage
Homepage
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com